LivaNova PLC announced that its OSPREY clinical research evaluating the aura6000 hypoglossal nerve stimulation program in individuals with obstructive rest apnea reached a good predictive consequence and will conclude enrollment before than predicted. This suggests there is a … [Read more...]
Genio Neurostimulator Reduces Sleep Apnea Severity
Nyxoah SAs Desire US pivotal analyze, made to assist the advertising and marketing authorization of the Genio hypoglossal nerve stimulation procedure for obstructive sleep apnea in the United States, achieved a statistically substantial reduction in the co-key endpoints of … [Read more...]
Sleep Apnea Positional Therapy Expands Reach to Caribbean
Sleep Specialists LLC, developers of the US Food and Drug Administration-cleared Zzoma positional therapy device, and ISD Health Solutions, a provider of sleep disorder treatment in the Caribbean, have partnered to bring Zzoma to patients with mild to moderate positional … [Read more...]
Sleep Apnea Ups Stroke Risk for White Patients But Not Black
The risk of stroke tied to sleep apnea may vary for Black people and white people, according to a study published in Neurology. The study found that white people diagnosed with sleep apnea, whether or not they used a continuous positive airway pressure machine (CPAP), were at … [Read more...]
Is Neurostimulation Cost-Effective for Mild Sleep Apnea?
A new exploratory analysis finds that using neuromuscular electrical stimulation as a treatment option for patients with mild obstructive sleep apnea may be cost-effective. Recent estimates suggest that 55 million adults in the United States have obstructive sleep apnea, with … [Read more...]